{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:49:59Z","timestamp":1787237399874,"version":"build-2736575974"},"reference-count":13,"publisher":"CMV Verlag","issue":"2","content-domain":{"domain":["rbmb.net"],"crossmark-restriction":false},"short-container-title":["rbmb.net"],"DOI":"10.29252\/rbmb.9.2.188","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T10:02:06Z","timestamp":1604484126000},"page":"188-192","update-policy":"https:\/\/doi.org\/10.29252\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Examining the Frequency of  the JAK2 (V617F) Mutation in Patients with Myeloproliferative Diseases in North Eastern Iran and the Effect of Treatment Intervention"],"prefix":"10.52547","volume":"9","author":[{"given":"Mojila","family":"Nasseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Biochemistry, Payamenoor University, Tehran, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Keyfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran & Pardis Clinical and Genetics Laboratory, Mashhad, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Rahbarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Biochemistry, Payamenoor university, Tehran, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Rajabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of biology, Payamenoor University, Tehran, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Abbaszadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Pardis Clinical and Genetics Laboratory, Mashhad, Iran & Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, MUMS, Mashhad, Iran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"28750","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-66884-0_19"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508423103"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-547760"},{"key":"ref4","unstructured":"Ghafari H, Karimzadeh P, Chahardouli B, Alimoghdam K, Ghavamzadeh A, Dargahi H, et al. Evaluation of JAK2V617F mutation prevalence in Myeloproliferative Neoplasm by AS-RT-PCR. Journal of Payavard Salamat.2009;3(2):94-101."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00361"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-015-0620-4"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/.20.10.3387-3395.2000"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cells3020546"},{"key":"ref9","unstructured":"Ebid GT, Ghareeb M, Salaheldin O, Kamel MM. Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients. Int J Clin Exp Pathol. 2015;8(9):11555-11559."},{"key":"ref10","unstructured":"Bagheri M, Abdirad I, Maleki D, Eyshi A, Valizadeh N. Acquired mutation of the tyrosine kinase JAK2 V617F in the ABL-BCR-negative chronic myeloproliferative diseases in a population of west Azerbaijan province, Iran. Journal of Isfahan Medical School. 2018;35(459):1785-1791."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2016.08.006"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404914"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.1996.d01-234.x"}],"container-title":["Reports of Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/rbmb.net\/article-1-396-en.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/rbmb.net\/article-1-396-en.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T06:15:36Z","timestamp":1619417736000},"score":1,"resource":{"primary":{"URL":"http:\/\/rbmb.net\/article-1-396-en.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.29252\/rbmb.9.2.188","relation":{},"ISSN":["2322-3480","2322-3480"],"issn-type":[{"value":"2322-3480","type":"print"},{"value":"2322-3480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"Varastegan Institute for Medical Sciences","name":"journal_owner","label":"Journal Owner"},{"value":"Varastegan Institute for Medical Sciences","name":"journal_publisher","label":"Journal Publisher"}]}}